99 related articles for article (PubMed ID: 576622)
1. Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-alpha-ergocryptine.
Medina D
J Natl Cancer Inst; 1977 Apr; 58(4):1107-10. PubMed ID: 576622
[TBL] [Abstract][Full Text] [Related]
2. Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
Welsch CW; Lambrecht LK; Hassett CC
J Natl Cancer Inst; 1977 Apr; 58(4):1135-8. PubMed ID: 576623
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of early preneoplastic lesions of the mammary gland.
Welsch CW
Cancer Res; 1976 Jul; 36(7 PT 2):2621-5. PubMed ID: 1277169
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the tumorigenicity of preneoplastic mammary nodule lines by enzymatic dissociation.
Medina D; Shepherd F; Gropp T
J Natl Cancer Inst; 1978 May; 60(5):1121-6. PubMed ID: 205661
[TBL] [Abstract][Full Text] [Related]
5. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice.
Medina D
J Natl Cancer Inst; 1976 Nov; 57(5):1185-9. PubMed ID: 187796
[TBL] [Abstract][Full Text] [Related]
6. Hormone dependence and estradiol receptors in the D series of mammary nodule outgrowth lines and tumors.
Medina D; Iramain CA; Clark JH
Cancer Res; 1975 Sep; 35(9):2355-69. PubMed ID: 167955
[TBL] [Abstract][Full Text] [Related]
7. Prolactin and the development and progression of early neoplastic mammary gland lesions.
Welsch CW
Cancer Res; 1978 Nov; 38(11 Pt 2):4054-8. PubMed ID: 698954
[TBL] [Abstract][Full Text] [Related]
8. Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
Briand P; Thorpe SM; Daehnfeldt JL
Br J Cancer; 1977 Jun; 35(6):816-21. PubMed ID: 577471
[TBL] [Abstract][Full Text] [Related]
9. Effects of pituitary graft and 2-bromo-alpha-ergocryptine on mammary DNA synthesis in mice in relation to mammary tumorigenesis.
Yanai R; Nagasawa H
J Natl Cancer Inst; 1976 May; 56(5):1055-6. PubMed ID: 1036504
[TBL] [Abstract][Full Text] [Related]
10. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
Tsai SJ; Loeffler DA; Heppner GH
Cancer Res; 1992 Apr; 52(8):2209-15. PubMed ID: 1559224
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.
Heuson JC; Waelbroeck C; Legros N; Gallez G; Robyn C; L'Hermite M
Gynecol Invest; 1971; 2(1):130-7. PubMed ID: 5170652
[No Abstract] [Full Text] [Related]
12. Estrogenic effects of nafoxidine on ovarian-dependent and independent mammary tumor lines in the mouse.
Watson CS; Medina D; Clark JH
Endocrinology; 1981 Feb; 108(2):668-72. PubMed ID: 7449742
[TBL] [Abstract][Full Text] [Related]
13. Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
Welsch CW
J Toxicol Environ Health Suppl; 1976; 1():161-75. PubMed ID: 1036505
[TBL] [Abstract][Full Text] [Related]
14. Considerations on the preneoplastic lesions of the mammary gland.
Gullino PM
Am J Pathol; 1977 Nov; 89(2):413-30. PubMed ID: 200144
[TBL] [Abstract][Full Text] [Related]
15. DNA polymerase activity and DNA synthesis in preneoplastic nodule outgrowths of BALB-c and C3H mouse mammary gland.
Banerjee MR; Mehta RG; Wagner JE
J Natl Cancer Inst; 1973 Feb; 50(2):339-45. PubMed ID: 4349763
[No Abstract] [Full Text] [Related]
16. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
Yanai R; Nagasawa H
J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
[No Abstract] [Full Text] [Related]
17. Androgen receptor content of nafoxidine treated experimentally induced canine prostatic hyperplasia.
Trachtenberg J
Clin Invest Med; 1985; 8(1):29-34. PubMed ID: 2580656
[TBL] [Abstract][Full Text] [Related]
18. Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice.
Smith GH; Vonderhaar BK; Graham DE; Medina D
Cancer Res; 1984 Aug; 44(8):3426-37. PubMed ID: 6430550
[TBL] [Abstract][Full Text] [Related]
19. Microcytotoxicity assay of immune responses to non-mammary tumor virus-induced, preneoplastic, and neoplastic mammary lesions in BALB/c mice.
Heppner GH; Kopp JS; Medina D
Cancer Res; 1976 Feb; 36(2 pt 2):753-8. PubMed ID: 1253160
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of nafoxidine in advanced breast cancer.
Steinbaum FL; De Jager RL; Krakoff IH
Med Pediatr Oncol; 1978; 4(2):123-6. PubMed ID: 661750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
